We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » Woodcock: GDUFA Reauthorization Tops CDER Priorities List for 2016
Woodcock: GDUFA Reauthorization Tops CDER Priorities List for 2016
The director of FDA’s CDER has laid out new priorities for the center to focus on in 2016, with negotiations for GDUFA and improvements at the Office of Generic Drugs among the center’s “front burner” priorities.